Sen. Grassley comments on FDA letter to drug maker about flawed Ketek study

Sen. Chuck Grassley issued the comment below about the warning letter (posted at http://www.fda.gov/cder/warn/warn2007) sent yesterday by the Food and Drug Administration to Sanofi-Aventis U.S. LLC regarding “objectionable conditions” found with the drug manufacturer’s conduct of the large safety study (3014) it submitted to make the case for FDA approval of the antibiotic Ketek. Sen. […]

Grassley: House Tax Proposal Could Undermine U.S. Companies’ Competitiveness

In 2004, Congress enacted legislation to repeal the Foreign Sales Corporation-Extraterritorial Income tax regime that was ruled a prohibited export subsidy by the World Trade Organization. By itself, repealing that regime would have caused a $50 billion tax increase on U.S. manufacturers over 10 years, so Congress also enacted an across-the-board effective tax rate cut […]

Grassley Announces Roundtable on Staff Discussion Draft on Non-profit Hospitals

WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, today announced a roundtable to discuss the committee minority staff discussion draft of potential reforms involving non-profit hospitals. The roundtable will be held on Tuesday, Oct. 30, from 2 p.m. to 5 p.m., in 215 Dirksen Senate Office Building. The roundtable will be […]

Grassley, Specter Introduce Transparency in Medical Device Pricing Act

WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, and Sen. Arlen Specter, ranking member of the Judiciary Committee, today introduced legislation to inject some much-needed transparency into the prices medical device suppliers charge hospitals participating in federal health care programs. The bill is meant to ensure that hospitals can provide care […]

Grassley, McCrery Seek Treasury Response on Taxpayer Impact of Delayed AMT Relief

WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, and Rep. Jim McCrery, ranking member of the Committee on Ways and Means, today asked the Treasury secretary for a detailed analysis of the impact on taxpayers of the Democratic-led Congress’ failure to extend Alternative Minimum Tax (AMT) relief so far this year. […]

Grassley Urges Export-Import Bank to Better Screen Funding Projects

WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, today urged the head of the Export-Import Bank to screen funding projects more carefully in the future in light of yesterday’s report pointing out shortcomings. The text of Grassley’s letter follows here. ###

Grassley, Roberts: CHIP Compromise Bill Does Not Extend Coverage to Families With $83,000 Incomes; HHS Retains Authority to Deny State Plan Amendments Inconsistent With CHIP

WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, and Sen. Pat Roberts, committee member, today reiterated that claims that the Children’s Health Insurance Program (CHIP) reauthorization bill, H.R. 976, expands coverage to children in families with incomes up to $83,000 are flatly incorrect. Likewise, the Administration’s claims that the Health and […]

Grassley: Report Shows Export-Import Bank is Not Screening Enough to Prevent Funding Projects that Hurt U.S. Industry, Including Ethanol

WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, today said a new report affirms his long-time concern that the Export-Import Bank of the United States is not screening potential funding projects carefully enough to ensure they don’t harm domestic industry. The screening process came to Grassley’s attention in 2004 when he […]